Evidence map›Paper›PMID 29348830›Full record

ArticleOncotarget2017

Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma.

Lichao Liu, Zhen Dong, Qian Lei, Jie Yang, Huanrong Hu, Qian Li, Yacong Ji, Leiyang Guo, Yanli Zhang, Yaling Liu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cloning and Characterization of YakAnimals : an open access journal from MDPI · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lichao Liu *Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Zhen Dong *State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400715, China.
Qian LeiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400715, China.
Jie YangState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400715, China.
Huanrong HuDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Qian LiDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Yacong JiDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Leiyang GuoDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Yanli ZhangDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Yaling LiuDepartment of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Hongjuan CuiState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400715, China.
Hebei Medical University · CNSouthwest University · CNState Key Laboratory of Silkworm Genomic BiologyThird Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma (MM) is one of the most malignant tumors and has a very poor prognosis. However, there are no effective drugs to treat this disease. As a kind of iron flavin dependent enzyme, dihydroorotate dehydrogenase (DHODH, EC 1.3.3.1) is the fourth and a key enzyme in the

Indexed as

autophagyBCL-2dihydroorotate dehydrogenase (DHODH)leflunomidemelanoma

Identifiers

PMID29348830
PMCPMC5762515
OpenAlexW2738657322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.